ovarian cancer, Johnson & Johnson

UK women plan to sue Johnson & Johnson over talcum powder cancer claims
British women who claim talcum powder gave them ovarian cancer are planning to take Johnson & Johnson to court, in the first legal suit the pharmaceutical giant has faced on the issue in the UK. Nearly 2,
Johnson & Johnson threatened with legal action in UK over talcum powder
Johnson & Johnson has been threatened with legal action in the UK over claims that its talcum powder products caused cancer. Law firm KP Law said on Wednesday that it had sent a pre-action letter to the US-based healthcare products company ahead of a potential group action lawsuit on behalf of cancer survivors,
Women plan UK legal action over talc cancer claims
Diagnosed with ovarian cancer in 2021, Cassandra Wardle is one of the women launching a group action against the biggest seller of talcum powder, Johnson & Johnson (J&J). Cassandra, who stumbled on a Facebook article linking cancer and talc following her diagnosis,
Johnson & Johnson Risks UK Lawsuit Over Talc Cancer Claim
UK claimants Wednesday announced legal action against US pharmaceutical and cosmetics giant Johnson & Johnson, alleging that women diagnosed with cancers were exposed to asbestos in the company's talcum powder.
Thousands of women plan legal action over alleged links between talc and cancer
Thousands of women plan legal action over alleged links between talc and cancer - If the action goes ahead it is understood to be the first of its kind against Johnson & Johnson in the UK.
What You Should Know About Ovarian Cancer Vaccines
Ovarian cancer vaccines are under development, but none are ready for primetime. There are no screening tools for ovarian ...
Cure Today20h
My Top 10 List for Living With Cancer
Nine years as an ovarian cancer “lifer” yields these tips for surviving and thriving when there’s no end of treatment ahead.
mayo4d
Project 1: Next-Generation TOP1 Inhibition To Treat Ovarian Cancer
TOP1 is the target of topotecan, which was approved in 1997 by the U.S. Food and Drug Administration (FDA) to treat relapsed ...
Medpage Today on MSN6d
Adding HIPEC Boosts Survival in Recurrent Ovarian Cancer
The 5-year OS rates were 46% in the HIPEC group versus 38% in the no-HIPEC group, they noted in Lancet Oncology. The trial ...
'Subtle' ovarian cancer symptoms you should never ignore, according to a gynaecologist
Ovarian cancer is the sixth most common cancer in women in the UK but the symptoms can be quite subtle, often leaving to a ...
AbbVie Gets European OK of Elahere in Platinum-Resistant Ovarian Cancer
Elahere, which won initial U.S. Food and Drug Administration approval in 2022 for platinum-resistant ovarian cancer and full approval earlier this year, was the key asset in AbbVie's $10.1 billion ...
The American Journal of Managed Care6d
Ovarian Cancer Survival Varies Widely Among Asian American Subgroups
Researchers found significant differences in ovarian cancer survival among Asian American subgroups, emphasizing the ...
Radio Iowa7d
UI is crafting a new drug to treat ovarian cancer
University of Iowa researchers have landed a $10-million federal grant to develop a new treatment for ovarian cancer. Jill ...
mayo4d
Project 4: Th17 T Cell-Inducing Vaccines for the Prevention of Ovarian Cancer Recurrence
It induces a specific type of immunity, called Th17 immunity, that seems to prevent suppression of the immune system. The ...
Pharmabiz1d
AbbVie receives European marketing approval for Elahere for the treatment of platinum-resistant ovarian cancer
AbbVie receives European marketing approval for Elahere for the treatment of platinum-resistant ovarian cancer: North Chicago, Illinois Tuesday, November 19, 2024, 10:00 Hrs [IST] ...
Bill proposes Medicaid cover cancer screening tests, crucial for early detection access
Multi-cancer Early Detection tests can screen for a variety of cancers that don't currently have annual screenings such as ...